Symptomatic Postnatal Cytomegalovirus Infection in Less than 32-Week Preterm Infants: 13-Year Retrospective Multicenter Case-Control Study
Neonatology · 2023
DOI: 10.1159/000529241 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Neonatology, 2023. Verfasst von Sarah Jane Corpuz Tapawan und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Newborn Care, Royal Hospital for Women, Randwick, New South Wales, Australia, janesa0301@gmail.com. Hauptthemen laut MEDLINE: Infant, Premature, Diseases, Lung Diseases, Cytomegalovirus Infections. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 44 Literaturangaben.
Themen: Neonatologie
Abstract (Originalsprache)
Introduction
Reports on the influence of postnatal cytomegalovirus (pCMV) infection in neonatal outcomes of preterm babies vary while guidance on management including screening is lacking. We aim to determine the association between symptomatic pCMV infection and chronic lung disease (CLD) and mortality in preterm infants born less than 32 weeks gestation.
Methods
We used data from the Neonatal Intensive Care Units’ (NICUS) population-based prospective data registry of infants in 10 neonatal units in New South Wales and the Australian Capital Territory, Australia. De-identified perinatal and neonatal outcome data for 40,933 infants were examined. We identified 172 infants <32 weeks gestation with symptomatic pCMV infection. Each was matched with one control infant.
Results
Infants with symptomatic pCMV infection were 2.7 times more likely to develop CLD (OR 2.7, 95% CI: 1.7–4.5) and spend 25.2 days more in hospital (95% CI: 15.2–35.2). Seventy-five percent (129/172) of infants with symptomatic pCMV were extremely preterm (<28 weeks). The mean age of symptomatic pCMV diagnosis was 62.5 ± 20.5 days or 34.7 ± 3.6 weeks-corrected gestational age. Ganciclovir treatment did not decrease CLD and death. CLD was 5.5 times predictive of death in patients with symptomatic pCMV infection. Symptomatic pCMV infection did not influence mortality nor increase neurologic impairment.
Conclusion
Symptomatic pCMV is a modifiable factor affecting extreme preterm infants with significant impact on CLD. Prospective study on screening and treatment will help unveil potential benefits in our already at-risk preterm infants.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Newborn Care, Royal Hospital for Women, Randwick, New South Wales, Australia, janesa0301@gmail.com.
- School of Women's and Children's Heath, University of New South Wales, Kensington, New South Wales, Australia, janesa0301@gmail.com.
- Critical Care Program, Westmead Hospital, Westmead, New South Wales, Australia.
- Department of Newborn Care, Royal Hospital for Women, Randwick, New South Wales, Australia.
- School of Women's and Children's Heath, University of New South Wales, Kensington, New South Wales, Australia.
- Department of Immunology and Infectious Disease, Sydney Children's Hospitals Network, Randwick, New South Wales, Australia.
Zitieren
APA
Tapawan, S. J. C., Bajuk, B., Oei, J. L., Palasanthiran, P., & NSW and the ACT Neonatal Intensive Care Units (NICUS) Group (2023). Symptomatic Postnatal Cytomegalovirus Infection in Less than 32-Week Preterm Infants: 13-Year Retrospective Multicenter Case-Control Study. Neonatology. https://doi.org/10.1159/000529241
Vancouver
Tapawan SJC, Bajuk B, Oei JL, Palasanthiran P, NSW and the ACT Neonatal Intensive Care Units (NICUS) Group. Symptomatic Postnatal Cytomegalovirus Infection in Less than 32-Week Preterm Infants: 13-Year Retrospective Multicenter Case-Control Study. Neonatology. 2023. doi:10.1159/000529241
BibTeX
@article{Tapawan2023,
author = {Tapawan, Sarah Jane Corpuz and Bajuk, Barbara and Oei, Ju Lee and Palasanthiran, Pamela and NSW and the ACT Neonatal Intensive Care Units (NICUS) Group, NSW and the ACT Neonatal Intensive Care Units (NICUS) Group},
title = {Symptomatic Postnatal Cytomegalovirus Infection in Less than 32-Week Preterm Infants: 13-Year Retrospective Multicenter Case-Control Study},
journal = {Neonatology},
year = {2023},
doi = {10.1159/000529241}
}
EUVIMED